Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Early and Sensitive Detection of Cisplatin-Induced Kidney Injury Using Novel Biomarkers

Kidney International Reports(2025)10.1016/j.ekir.2025.01.035Source: DataRank Database

Early and Sensitive Detection of Cisplatin-Induced Kidney Injury Using Novel Biomarkers is a research paper published in Kidney International Reports (2025). On theSindex it has a DataRank of 0.292. It has been cited 6 times.

N/A

0.292DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 5.01)OA: goldTopics (18)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.292

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (8)

Gary S. Friedman ORCID,Xavier Benain ORCID,Nunzio Camerlingo ORCID,Stefan Sultana ORCID,Shiran Shapira ORCID

Live enrichment

PubMed:40303198 PMC:PMC12034874 OpenAlex:https://openalex.org/W4407157968

Health Research Board

Grant: unidentified

unidentified

European Commission

Grant: 115003

SAFER AND FASTER EVIDENCE-BASED TRANSLATION

U.S. Food and Drug Administration

Innovative Medicines Initiative

European Medicines Agency

FWCI

5.01

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.kireports.org/article/S2468-0249(25)00060-9/pdf

publisherhttps://www.kireports.org/article/S2468-0249(25)00060-9/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2468024925000609?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2468024925000609?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ekir.2025.01.035

Fields of Study

Chemotherapy-induced organ toxicity mitigationChemotherapy-induced cardiotoxicity and mitigationChemotherapy-related skin toxicity0303 health sciences03 medical and health sciences

Keywords

MedicineCisplatinAcute kidney injuryOncologyCancer researchInternal medicineChemotherapyBiomarkersDrug-induced Kidney InjurySubclinical Acute Kidney InjuryClinical ResearchRC870-923Diseases of the genitourinary system. Urology

Sustainable Development Goals

SDG 0: Good health and well-being

Early and Sensitive Detection of Cisplatin-Induced Kidney Injury Using Novel Biomarkers

FAIR Checklist

DataRank Breakdown

Authors (8)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)